Bethany College is a private four-year Christian liberal arts college in Lindsborg, Kansas, United States, associated with the Evangelical Lutheran Church of America. It was founded in 1881, making it one of the oldest colleges in Kansas..
Purpose/Objective(s) As active surveillance expands to selected favorable intermediate-risk patients, improved identification of high-grade disease at diagnosis is increasingly important. We hypothesized that baseline erectile dysfunction (ED) severity identifies patients more likely to harbor high-grade prostate cancer at presentation. Materials/Methods We analyzed 2,445 consecutive patients treated with low-dose-rate brachytherapy (2001–2018) who completed a pretreatment IIEF-6 questionnaire without pharmacologic or mechanical support. ED severity was classified as severe (1–10), moderate/mild (11–24), or normal (25–30). Associations between ED severity and PSA, percent positive biopsies, Gleason group, NCCN risk category, and comorbidities were evaluated using chi-square and multivariable logistic regression models adjusting for age. Results Severe ED was significantly associated with higher PSA (p=0.008), greater percent positive biopsies (p=0.002), and higher Gleason group distribution (p<0.001). Patients with severe ED more frequently harbored Gleason group 4–5 disease compared with those with normal erectile function. ED severity was also associated with increased prevalence of hypertension, diabetes, cardiovascular disease, and tobacco exposure (all p<0.001). Conclusion Baseline ED severity identifies patients more likely to harbor high-grade disease at diagnosis, independent of age. In the era of expanding active surveillance, ED severity may represent a readily available host-level biomarker that identifies patients who could benefit from intensified diagnostic evaluation and monitoring.
Purpose Conventional standard prostate biopsy techniques underestimate tumor grade and volume in up to 40% of cases. The integration of MRI into biopsy protocols has improved accuracy, but MRI still misses 15% of clinically significant cancers. Transperineal approaches with either a local anesthesia (laTP) or operating room (transperineal template guided mapping biopsy- TTMB) technique provides biopsy access to the entirety of the gland with sampling of all anatomic regions. In this study, we evaluate whether the extent of prostate biopsy impacts oncologic outcomes to include biochemical failure (BF), prostate cancer-specific mortality (PCSM), and overall mortality (OM). Materials and Methods This was a prospective, single institution cohort study of 3093 consecutive patients treated with low-dose rate brachytherapy (91.1% Pd-103) for clinically localized prostate cancer from April 1995-November 2018. Patients were stratified by the number of prostate biopsy cores and biopsy technique (1-17/TRUS, 18-30/laTP, >30/TTMB). Post-implant dosimetry was based on day 0 CT evaluation. BF was defined as a PSA> 0.40 after nadir. Patients with metastatic prostate cancer or non-metastatic castrate resistant disease who died of any cause were classified as dead of prostate cancer. All other deaths were attributable to the immediate cause of death. Multiple clinical, diagnostic, pathologic, and treatment parameters were analyzed for impact on survival outcomes. Results The median patient age was 65 years and the median pre-treatment PSA was 6.2ng/ml. The median f/u was 11.1 years (TRUS 12.1, laTP 5.3, TTMB 8.8 years, respectively, p<0.001). The TTMB cohort presented with lower pre-treatment PSA (p=0.003), lesser clinical stage (p<0.001), but were diagnosed with higher Gleason Group (GG) (p<0.001), were less likely to receive ADT (p<0.001) and more likely to receive EBRT (p<0.001). The median post-treatment PSA in biochemically controlled patients was <0.01 ng/ml. TTMB decreased BF for low, favorable and unfavorable risk groups but not high risk when compared to TRUS or laTP (p=0.009). TTMB reduced PCSM for GG 1-4 (p=0.01), but not GG5. In Fine-Gray analysis, BF was best predictedby TTMB (SHR 0.434:95% CI 0.200-0.940; p<0.001) and GG (SHR 3.397:95% CI 2.456-4.204; o<0.001). PCSM was most closely related to GG (SHR 6.232: 95% CI 3.065-12.669; p<0.001), while in Cox regression, OM was impacted by age (HR 1.095:95% CI 1.085-1.106; p<0.001) and number of comorbidities (HR 1.579: 95% CI 1.371-1.187; p<0.001). Conclusion Despite the ability of laTP to biopsy all regions of the prostate gland with substantially more biopsy cores, significant improvements in oncologic outcomes were not discerned when compared to TRUS. In contrast, 3-dimensional mapping (TTMB) diagnosed more high grade lesions, improved biochemical control and decreased PCSM for all patients except those with high risk disease or GG5 histology. Despite TTMB’s ability to more accurately determine tumor grade and volume, to optimize treatment planning and to improve oncologic outcomes, TTMB has not been universally accepted because of labor intensiveness and the integration of MRI into biopsy algorithms.
Purpose Erectile dysfunction (ED) may represent early systemic vascular disease due to small-vessel atherosclerosis. We hypothesized that baseline ED severity independently predicts cardiovascular-specific mortality following definitive prostate radiation therapy and functions as a clinically accessible vascular biomarker. Materials and Methods We analyzed 2,445 consecutive patients treated with low-dose-rate brachytherapy (2001-2018) who completed a pretreatment IIEF-6 questionnaire without pharmacologic or mechanical support. ED severity was classified as severe (1-10), moderate/mild (11-24), or normal (25-30). The primary endpoint was cardiovascular-specific mortality. Secondary endpoints included overall mortality (OM), biochemical failure, and prostate cancer-specific mortality (PCSM). Cox regression evaluated OM, and competing risk regression (Fine and Gray) assessed cardiovascular death. Multivariable models adjusted for age, PSA, Gleason group, ADT, EBRT, hypertension, diabetes, tobacco use, cardiovascular disease, and comorbidity burden. Results At a median follow-up of 10 years, severe ED independently predicted worse OM (vs normal function HR 0.68, p<0.001). The association between ED severity and OM was significant in patients aged 60-69 and ≥70, but not in those ≤59 years. In competing risk analysis, ED severity was strongly associated with cardiovascular mortality (overall p<0.001). Compared with severe ED, normal erectile function was associated with a 65% relative reduction in cardiovascular death (HR 0.35, p<0.001), independent of established cardiovascular disease and risk factors. ED severity was not associated with biochemical failure (p=0.682) or PCSM (p=0.649). Conclusions Baseline ED severity independently predicts cardiovascular mortality—but not prostate cancer-specific death—after definitive radiation therapy. These findings support ED as a readily available vascular biomarker within oncology practice. Incorporating ED severity into routine assessment may identify patients at increased cardiovascular risk and create an opportunity for earlier preventive intervention.
AI's increasing presence in space exploration platforms has allowed mission opportunities from autonomous navigation to real-time anomaly detection. However, this progress brings with it a new category of cybersecurity problems that traditional cybersecurity models do not expect. This paper provides a comprehensive review of the adversarial attack vectors for AI systems in space environments, such as input manipulation, poisoning of training data, degradation of AI models, and exploitation of the supply chain. Based on the 2022 incident with ViaSat KA-SAT, which knocked out approximately 45,000 modems in Europe, this research highlights major shortcomings of today's space security stances. It is proposed to implement a five-layer defense-in-depth approach, based on guidance from NIST CSF 2.0 [5], NIST AI RMF 1.0 [6], MITRE ATLAS [7], and CCSDS standards [9]. Architecture is designed to address data integrity, model robustness, infrastructure hardening, encrypted communications, and autonomous operational resilience, all of which are specific to space deployment restrictions. The framework is validated as it is practically effective in the case of the KA-SAT attack chain.
Digital twins (DTs), a technology of Industry 4.0 and 5.0, are now playing a pivotal role in the real-time virtual representation of physical assets in manufacturing, aerospace, healthcare, and smart cities. The close coupling of the cyber and physical domains, however, creates a large and novel attack surface that is not well covered by traditional security frameworks. The Secure-AI Twin (SAT) framework is introduced in this paper as an all-encompassing cybersecurity concept for AI-powered digital twins covering four key areas: Vulnerability analysis throughout DT ecosystems, Anomaly detection using AI, Industrial IoT and Industry 5.0 security, and Real-time cyber-physical threat mitigation. The proposed multi-layered defense architecture has been implemented using advances in federated learning, explainable AI, and neural-network-based threat detection, resulting in a 27.4% increase in threat detection accuracy and a 21.2% decrease in latency. The framework tackles the challenges of fidelity, real-time synchronization, and security, known as the "Digital Twin Trilemma," with an integrated solution that includes blockchain-supported federated learning, autoencoder-based anomaly detection, and dynamic incident response. The framework has been proven effective against sophisticated cyber-physical attacks in both industrial control systems and IIoT environments through experimental validation